A Case of Clarithromycin-induced Eosinophilic Pneumonia and Myocarditis
Abstract
Acute eosinophilic pneumonia (AEP) is a rare disease with unknown etiology that is characterised by pulmonary infiltration in radiography and eosinophilic infiltration into the lungs. Clarithromycin is a commonly used and well tolerated antibiotic. A 31-year-old male asthma patient was admitted with dyspnea, fever, and sputum. Despite the clarithromycin treatment the patient’s complaints worsened. Leukocytes was 23400/ml (eosinophil 8%). We re-applied ampicillin-sulbactam and clarithromycin. Since leukocytosis and fever were persisting, antibiotics were withdrawn and cefepim, teicoplanin, and ciprofloxacin were started. Because the patient developed chest pain and his dyspnea worsened, we diagnosed the patient with myocardititis after the cardiac evaluation. The tomography showed pleural effusion and consolidation. Sputum, blood, and tracheal aspirates showed no microorganism production. No parasites were found in feces, either. Leukocyte and eosinophil levels got worsened. The patient was then diagnosed with eosinophilic pneumonia. After methylprednisolon was administrated, laboratory, radiological, and clinical findings improved. This case suggests that eosinophilic pneumonia should be considered in the differential diagnosis of patients with pneumonia who do not respond to treatment.
Key Words: Clarithromycin; Eosinophilic Pneumonia; Myocarditis
Keywords
Kaynakça
- Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989;321:569-74.
- Yalnız E. Eozinofilik akciğer hastalıkları,Editör;Tabak L, Kumbasar Ö. Diffüz parankimal akciğer hastalıkları,1.baskı,İstanbul,AVES yayınevi,2013;180-94.
- Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore) 1996;75:334-42.
- Amayasu H, Yoshida S, Ebana S, Yamamoto Y, Nishikawa T, Shoji T, et al. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000;84:594-8.
- Zalewska-Kaszubska J, Gorska D. Anti-inflammatory capabilities of macrolides. Pharmacol Res 2001;44:451-4.
- Meguro H, Arimasu O, Hiruma F, Sugamata K, Sugie N, Higa A et al. Clinical evaluation of clarithromycin, a new macrolide antibiotic in children. Jpn J Antibiot 1989;42:255-62.
- Kränke B, Aberer W. Macrolide-induced Churg-Strauss syndrome in patient with atopy. Lancet 1997;350:1551-2.
- Demoly P, Benahmed S, Valembois M, Sahla H, Messaad D, Godard P, et al. L’allergie aux macrolides. Presse Med 2000;29:321-6.
Ayrıntılar
Birincil Dil
Tr
Konular
-
Bölüm
-
Yayımlanma Tarihi
11 Aralık 2015
Gönderilme Tarihi
11 Aralık 2015
Kabul Tarihi
-
Yayımlandığı Sayı
Yıl 2015 Cilt: 22 Sayı: 2